RadNet (RDNT) Expected to Post Earnings on Friday

RadNet (NASDAQ:RDNT) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect the company to announce earnings of $0.21 per share and revenue of $459.42 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

RadNet Price Performance

NASDAQ:RDNT opened at $59.33 on Thursday. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16. RadNet has a one year low of $36.47 and a one year high of $93.65. The company has a fifty day moving average price of $66.31 and a 200 day moving average price of $69.19. The stock has a market cap of $4.39 billion, a P/E ratio of -847.45 and a beta of 1.79.

Analysts Set New Price Targets

A number of research analysts have recently commented on RDNT shares. Truist Financial reaffirmed a “buy” rating and set a $88.00 price objective (down previously from $94.00) on shares of RadNet in a research report on Wednesday, January 22nd. Jefferies Financial Group cut their price target on RadNet from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, January 15th. Finally, Barclays reduced their price objective on RadNet from $85.00 to $74.00 and set an “overweight” rating for the company in a research report on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $75.50.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.